Brokerages Set National Health Investors, Inc. (NYSE:NHI) PT at $73.29

Shares of National Health Investors, Inc. (NYSE:NHI) have been assigned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the stock, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $73.29.

Several equities analysts recently commented on the company. Wells Fargo & Company downgraded National Health Investors from an “overweight” rating to an “equal weight” rating and raised their target price for the stock from $81.00 to $86.00 in a research report on Tuesday, October 1st. Truist Financial boosted their target price on shares of National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research note on Friday, August 30th. Bank of America assumed coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 target price for the company. Finally, StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th.

National Health Investors Price Performance

NYSE:NHI opened at $75.17 on Thursday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 10.27 and a current ratio of 10.27. The company has a 50-day moving average of $80.55 and a 200-day moving average of $72.19. National Health Investors has a 52 week low of $48.97 and a 52 week high of $86.13. The company has a market capitalization of $3.27 billion, a price-to-earnings ratio of 25.57, a PEG ratio of 4.73 and a beta of 1.04.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 EPS for the quarter, missing analysts’ consensus estimates of $1.10 by ($0.29). The business had revenue of $84.97 million for the quarter, compared to the consensus estimate of $64.95 million. National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The firm’s revenue for the quarter was up 9.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.06 EPS. As a group, equities research analysts anticipate that National Health Investors will post 4.52 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Friday, September 27th will be given a dividend of $0.90 per share. The ex-dividend date is Friday, September 27th. This represents a $3.60 annualized dividend and a yield of 4.79%. National Health Investors’s dividend payout ratio (DPR) is 122.45%.

Institutional Investors Weigh In On National Health Investors

Several hedge funds and other institutional investors have recently added to or reduced their stakes in NHI. PNC Financial Services Group Inc. grew its stake in shares of National Health Investors by 6.4% during the fourth quarter. PNC Financial Services Group Inc. now owns 3,979 shares of the real estate investment trust’s stock valued at $222,000 after purchasing an additional 238 shares during the last quarter. DGS Capital Management LLC bought a new stake in shares of National Health Investors during the first quarter worth $232,000. Allspring Global Investments Holdings LLC lifted its stake in shares of National Health Investors by 66.2% during the first quarter. Allspring Global Investments Holdings LLC now owns 2,594 shares of the real estate investment trust’s stock valued at $163,000 after acquiring an additional 1,033 shares during the period. Sumitomo Mitsui Trust Holdings Inc. lifted its stake in shares of National Health Investors by 9.9% during the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 407,855 shares of the real estate investment trust’s stock valued at $25,626,000 after acquiring an additional 36,653 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. boosted its holdings in National Health Investors by 4.6% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 197,863 shares of the real estate investment trust’s stock valued at $12,432,000 after acquiring an additional 8,642 shares during the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.